Abstract:Thirteen clinical variables related to survival status were selected for modeling and analysis. During our observation period, nomograms provided a more reliable prognostic assessment of NSCLC patients compared to machine‐learning models. In practical clinical applications, an integrated model combining these two approaches may demonstrate superior capabilities. Background Most patients with advanced non‐small cell lung cancer (NSCLC) have a poor prognosis. Predicting overall survival using clinical data would benefit cancer patients by allowing providers to design an optimum treatment plan. We compared the performance of nomograms with machine‐learning models at predicting the overall survival of NSCLC patients. This comparison benefits the development and selection of models during the clinical decision‐making process for NSCLC patients. Methods Multiple machine‐learning models were used in a retrospective cohort of 6586 patients. First, we modeled and validated a nomogram to predict the overall survival of NSCLC patients. Subsequently, five machine‐learning models (logistic regression, random forest, XGBoost, decision tree, and light gradient boosting machine) were used to predict survival status. Next, we evaluated the performance of the models. Finally, the machine‐learning model with the highest accuracy was chosen for comparison with the nomogram at predicting survival status by observing a novel performance measure: time‐dependent prediction accuracy. Results Among the five machine‐learning models, the accuracy of random forest model outperformed the others. Compared with the nomogram for time‐dependent prediction accuracy with a follow‐up time ranging from 12 to 60 months, the prediction accuracies of both the nomogram and machine‐learning models changed as time varied. The nomogram reached a maximum prediction accuracy of 0.85 in the 60th month, and the random forest algorithm reached a maximum prediction accuracy of 0.74 in the 13th month. Conclusions Overall, the nomogram provided more reliable prognostic assessments of NSCLC patients than machine‐learning models over our observation period. Although machine‐learning methods have been widely adopted for predicting clinical prognoses in recent studies, the conventional nomogram was competitive. In real clinical applications, a comprehensive model that combines these two methods may demonstrate superior capabilities.

Effect of machine learning methods on predicting NSCLC overall survival time based on Radiomics analysis

Radiomics Model Based on Intratumoral and Peritumoral Features for Predicting Major Pathological Response in Non-Small Cell Lung Cancer Receiving Neoadjuvant Immunochemotherapy

Prognostic Prediction of Cancer Based on Radiomics Features of Diagnostic Imaging: The Performance of Machine Learning Strategies

Radiomics-based Prognosis Analysis for Non-Small Cell Lung Cancer

Using Nomogram and Machine Learning Models to Predict Non-Small Cell Lung Cancer Prognosis

Integrating Radiomics with Genomics for Non-Small Cell Lung Cancer Survival Analysis.

Preoperative computed tomography-based tumoral radiomic features prediction for overall survival in resectable non-small cell lung cancer

Machine Learning-Based Radiomics for Predicting Outcomes in Cervical Cancer Patients Undergoing Concurrent Chemoradiotherapy

CT-derived radiomic analysis for predicting the survival rate of patients with non-small cell lung cancer receiving radiotherapy

Comparison of nomogram and machine‐learning methods for predicting the survival of non‐small cell lung cancer patients

Improved Prognostication of Overall Survival after Radiotherapy in Lung Cancer Patients by an Interpretable Machine Learning Model Integrating Lung and Tumor Radiomics and Clinical Parameters

Machine Learning-Based Prediction of Pathological Responses and Prognosis After Neoadjuvant Chemotherapy for Non–Small-Cell Lung Cancer: A Retrospective Study

Predicting survival time of lung cancer patients using radiomic analysis

Advancing NSCLC pathological subtype prediction with interpretable machine learning: a comprehensive radiomics-based approach

Machine learning-based radiomics strategy for prediction of cell proliferation in non-small cell lung cancer

A novel machine learning model for efficacy prediction of immunotherapy-chemotherapy in NSCLC based on CT radiomics

A deep learning‐ and CT image‐based prognostic model for the prediction of survival in non‐small cell lung cancer

PET/CT radiomics and machine learning enable non-invasive survival stratification and histologic tumor risk profiling in patients with lung adenocarcinoma

Enhancing Survival Outcome Predictions in Metastatic Non-Small Cell Lung Cancer Through PET Radiomics Analysis

Radiomics-Clinical AI Model with Probability Weighted Strategy for Prognosis Prediction in Non-Small Cell Lung Cancer

Development of a Radiomics Nomogram Based on the 2D and 3D CT Features to Predict the Survival of Non-Small Cell Lung Cancer Patients